Ferrous Fumarate Dosing for Pediatric Patients

Elemental Iron Content

The American Journal of Kidney Diseases recommends that ferrous fumarate contains 108 mg of elemental iron per 325 mg tablet, making it the most iron-dense oral preparation compared to ferrous sulfate or ferrous gluconate 1
This higher elemental iron content allows for smaller pill burden when calculating pediatric doses, according to the American Journal of Kidney Diseases 1

The American Journal of Kidney Diseases suggests that the standard dose is 2 to 3 mg/kg/day of elemental iron, divided into 2 to 3 doses throughout the day, for pediatric patients 1, 2, 3
For a 10 kg child, this translates to 20-30 mg of elemental iron daily, which equals approximately 60-90 mg of ferrous fumarate salt per day, as recommended by the American Journal of Kidney Diseases 1

The American Academy of Pediatrics recommends that for treatment of confirmed iron deficiency anemia, use 3 mg/kg/day of elemental iron given between meals to maximize absorption, although this specific guideline is from Praxis Medical Insights, a similar recommendation may be found from other societies 4
However, a more suitable recommendation from the American Journal of Kidney Diseases is that iron should be administered on an empty stomach, as food reduces iron absorption by up to 50% 1, 2

The American Journal of Kidney Diseases recommends that iron should be administered on an empty stomach, as food reduces iron absorption by up to 50% 1, 2
Specifically, the American Journal of Kidney Diseases suggests avoiding giving iron within 2 hours before or 1 hour after meals 1
The American Journal of Kidney Diseases also notes that aluminum-based phosphate binders reduce iron absorption and should be separated from iron dosing 1

The American Journal of Kidney Diseases recommends that liquid iron preparations are more appropriate for young pediatric patients than solid dose forms 3
The American Journal of Kidney Diseases suggests that ferrous fumarate, ferrous sulfate, and ferrous gluconate are all acceptable ionic iron salts that provide known amounts of elemental iron 1, 2

If gastrointestinal side effects occur, the American Journal of Kidney Diseases recommends reducing to smaller, more frequent doses or considering alternate-day dosing rather than discontinuing therapy 1
The American Journal of Kidney Diseases suggests that mild gastrointestinal symptoms should not necessarily prompt discontinuation, although this is also recommended by Praxis Medical Insights, a similar recommendation may be found from other societies 4
Starting with a lower dose and gradually increasing to target may improve tolerance, as recommended by the American Journal of Kidney Diseases 1

The American Academy of Pediatrics recommends rechecking hemoglobin after 4 weeks of treatment, if no response despite compliance, further evaluation with MCV, RDW, and serum ferritin is needed, although this specific guideline is from Praxis Medical Insights, a similar recommendation may be found from other societies 4
Systemic iron toxicity with hepatocellular damage has been reported with excessive iron administration in pediatric patients, emphasizing the importance of proper dosing, as noted by Praxis Medical Insights, although a similar warning may be found from other societies 4

Ferrous fumarate tablets contain about 33 % elemental iron by weight, delivering roughly 108 mg elemental iron per 325 mg tablet (equivalent to 69–106 mg in standard tablet formulations) 5.

The liquid formulation of ferrous fumarate provides approximately 45 mg elemental iron per 5 mL, making it appropriate for infants and young children who cannot swallow tablets 5.

Food, tea, coffee, and dairy products significantly reduce iron absorption; giving ferrous fumarate on an empty stomach (at least 2 hours before or 1 hour after meals) avoids up‑to‑50 % absorption loss and prevents inhibition by these beverages 6.

Alternate‑day dosing of ferrous fumarate may improve gastrointestinal tolerability while maintaining efficacy in pediatric iron‑deficiency anemia 5.

For children who show no hematologic response after 4 weeks of oral ferrous fumarate despite confirmed adherence, intravenous iron should be considered when malabsorption is suspected 6.